Coeliac disease: From triggering factors to treatment

International Journal of Celiac Disease

Volumn 1, Issue 1, 2013, Pages 9-13

  Sziksz, Erna ^a,b   Vörös, Péter ^b   Veres, Gábor ^b   Fekete, Andrea ^a,b   Vannay, Ádám ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Coeliac disease; Pathomechanism; Therapy; Triggering factors

Indexed keywords

EID: 84919337012     PISSN: 23343427     EISSN: 23343486     Source Type: Journal    
DOI: 10.12691/ijcd-1-1-5     Document Type: Article

References (49)

1. Setty, M., Hormaza, L., Guandalini, S. Celiac disease: risk assessment, diagnosis, and monitoring. Molecular diagnosis & therapy, 12 (5):289-98. 2008.
2. Green, P.H., Cellier, C. Celiac disease. The New England journal of medicine, 357 (17):1731-43. 2007.
3. Makovicky, P., Rimarova, K., Boor, A., Makovicky, P., Vodicka, P., Samasca, G., Kruzliak, P. Correlation between antibodies and histology in celiac disease: incidence of celiac disease is higher than expected in the pediatric population. Molecular medicine reports, 8 (4):1079-83. 2013.
4. Rubio-Tapia, A., Murray, J.A. Classification and management of refractory coeliac disease. Gut, 59 (4):547-57. 2010
5. Baldassarre, M., Laneve, A.M., Grosso, R., Laforgia, N. Celiac disease: pathogenesis and novel therapeutic strategies. Endocrine, metabolic & immune disorders drug targets, 8 (3):152-8. 2008.
6. Jabri, B., Sollid, L.M. Mechanisms of disease: immunopathogenesis of celiac disease. Nature clinical practice. Gastroenterology & hepatology, 3 (9): 516-25. 2006.
7. Rostom, A., Dube, C., Cranney, A., Saloojee, N., Sy, R., Garritty, C., Sampson, M., Zhang, L., Yazdi, F., Mamaladze, V., Pan, I., MacNeil, J., Mack, D., Patel, D., Moher, D. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology, 128 (4 Suppl 1):S38-46. 2005.
8. Lauret, E., Rodrigo, L. Celiac disease and autoimmune-associated conditions. BioMed research international, 2013:127589. 2013.
9. Schuppan, D., Dennis, M.D., Kelly, C.P. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutrition in clinical care: an official publication of Tufts University, 8 (2):54-69. 2005.
10. Karell, K., Louka, A.S., Moodie, S.J., Ascher, H., Clot, F., Greco, L., Ciclitira, P.J., Sollid, L.M., Partanen, J., European Genetics Cluster on Celiac, D. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Human immunology, 64 (4):469-77. 2003.
11. Shan, L., Molberg, O., Parrot, I., Hausch, F., Filiz, F., Gray, G.M., Sollid, L.M., Khosla, C. Structural basis for gluten intolerance in celiac sprue. Science, 297 (5590):2275-9. 2002
12. Caccamo, D., Curro, M., Ientile, R. Potential of transglutaminase 2 as a therapeutic target. Expert opinion on therapeutic targets, 14 (9):989-1003. 2010.
13. Sollid, L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nature reviews. Immunology, 2 (9):647-55. 2002.
14. Lewis, K., McKay, D.M. Metabolic stress evokes decreases in epithelial barrier function. Annals of the New York Academy of Sciences, 1165:327-37. 2009.
15. Szaflarska-Poplawska, A., Siomek, A., Czerwionka-Szaflarska, M., Gackowski, D., Rozalski, R., Guz, J., Szpila, A., Zarakowska, E., Olinski, R. Oxidatively damaged DNA/oxidative stress in children with celiac disease. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19 (8):1960-5. 2010.
16. Schuppan, D., Junker, Y., Barisani, D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology, 137 (6):1912-33. 2009.
17. Szebeni, B., Veres, G., Dezsofi, A., Rusai, K., Vannay, A., Bokodi, G., Vasarhelyi, B., Korponay-Szabo, I.R., Tulassay, T., Arato, A. Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease. Journal of pediatric gastroenterology and nutrition, 45 (2):187-93. 2007.
18. Iltanen, S., Rantala, I., Laippala, P., Holm, K., Partanen, J., Maki, M. Expression of HSP-65 in jejunal epithelial cells in patients clinically suspected of coeliac disease. Autoimmunity, 31 (2):125-32. 1999.
19. Sziksz, E., Veres, G., Vannay, A., Prokai, A., Gal, K., Onody, A., Korponay-Szabo, I.R., Reusz, G., Szabo, A., Tulassay, T., Arato, A., Szebeni, B. Increased heat shock protein 72 expression in celiac disease. Journal of pediatric gastroenterology and nutrition, 51 (5):573-8. 2010.
20. Li, Z., Menoret, A., Srivastava, P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Current opinion in immunology, 14 (1):45-51. 2002.
21. Takeda, K., Kaisho, T., Akira, S. Toll-like receptors. Annual review of immunology, 21:335-76. 2003.
22. Jeon, M.K., Klaus, C., Kaemmerer, E., Gassler, N. Intestinal barrier: Molecular pathways and modifiers. World journal of gastrointestinal pathophysiology, 4 (4):94-99. 2013.
23. Laukoetter, M.G., Bruewer, M., Nusrat, A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Current opinion in gastroenterology, 22 (2):85-9. 2006.
24. Fasano, A. Zonulin, regulation of tight junctions, and autoimmune diseases. Annals of the New York Academy of Sciences, 1258:25-33. 2012.
25. Tripathi, A., Lammers, K.M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M.S., Antalis, T.M., Vogel, S.N., Zhao, A., Yang, S., Arrietta, M.C., Meddings, J.B., Fasano, A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences of the United States of America, 106 (39):16799-804. 2009.
26. Catalioto, R.M., Maggi, C.A., Giuliani, S. Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Current medicinal chemistry, 18 (3):398-426. 2011.
27. Niecknig, H., Tug, S., Reyes, B.D., Kirsch, M., Fandrey, J., Berchner-Pfannschmidt, U. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free radical research, 46 (6):705-17. 2012.
28. Diosdado, B., van Oort, E., Wijmenga, C. "Coelionomics": towards understanding the molecular pathology of coeliac disease. Clinical chemistry and laboratory medicine: CCLM/FESCC, 43 (7):685-95. 2005.
29. Vasseur, S., Afzal, S., Tardivel-Lacombe, J., Park, D.S., Iovanna, J.L., Mak, T.W. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proceedings of the National Academy of Sciences of the United States of America, 106 (4):1111-6. 2009.
30. Voros, P., Sziksz, E., Himer, L., Onody, A., Pap, D., Frivolt, K., Szebeni, B., Lippai, R., Gyorffy, H., Fekete, A., Brandt, F., Molnar, K., Veres, G., Arato, A., Tulassay, T., Vannay, A. Expression of PARK7 is increased in celiac disease. Virchows Archiv: an international journal of pathology, 463 (3):401-8. 2013.
31. Vannay, A., Sziksz, E., Prokai, A., Veres, G., Molnar, K., Szakal, D.N., Onody, A., Korponay-Szabo, I.R., Szabo, A., Tulassay, T., Arato, A., Szebeni, B. Increased expression of hypoxia-inducible factor 1alpha in coeliac disease. Pediatric research, 68 (2):118-22. 2010.
32. Lee, A., Newman, J.M. Celiac diet: its impact on quality of life. Journal of the American Dietetic Association, 103 (11):1533-5. 2003.
33. Rashtak, S., Murray, J.A. Review article: coeliac disease, new approaches to therapy. Alimentary pharmacology & therapeutics, 35 (7):768-81. 2012.
34. van den Broeck, H.C., van Herpen, T.W., Schuit, C., Salentijn, E.M., Dekking, L., Bosch, D., Hamer, R.J., Smulders, M.J., Gilissen, L.J., van der Meer, I.M. Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines. BMC plant biology, 9:41. 2009.
35. Gass, J., Bethune, M.T., Siegel, M., Spencer, A., Khosla, C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology, 133 (2):472-80. 2007.
36. Senger, S., Luongo, D., Maurano, F., Mazzeo, M.F., Siciliano, R.A., Gianfrani, C., David, C., Troncone, R., Auricchio, S., Rossi, M. Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunology letters, 88 (2):127-34. 2003.
37. Aziz, I., Evans, K.E., Papageorgiou, V., Sanders, D.S. Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? Journal of gastrointestinal and liver diseases: JGLD, 20 (1):27-31. 2011.
38. Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Rispo, A., Griffin, M., Issekutz, T., Quaratino, S., Londei, M. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology, 129 (5):1400-13. 2005.
39. Xia, J., Bergseng, E., Fleckenstein, B., Siegel, M., Kim, C.Y., Khosla, C., Sollid, L.M. Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease. Bioorganic & medicinal chemistry, 15 (20):6565-73. 2007.
40. Rivera-Nieves, J., Ho, J., Bamias, G., Ivashkina, N., Ley, K., Oppermann, M., Cominelli, F. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology, 131 (5):1518-29. 2006.
41. Booth, V., Keizer, D.W., Kamphuis, M.B., Clark-Lewis, I., Sykes, B.D. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry, 41 (33):10418-25. 2002.
42. Gillett, H.R., Arnott, I.D., McIntyre, M., Campbell, S., Dahele, A., Priest, M., Jackson, R., Ghosh, S. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology, 122 (3):800-5. 2002.
43. Bethune, M.T., Siegel, M., Howles-Banerji, S., Khosla, C. Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. The Journal of pharmacology and experimental therapeutics, 329 (2):657-68. 2009.
44. Anderson, R.P., van Heel, D.A., Tye-Din, J.A., Jewell, D.P., Hill, A.V. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut, 55 (4):485-91. 2006.
45. Paterson, B.M., Lammers, K.M., Arrieta, M.C., Fasano, A., Meddings, J.B. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Alimentary pharmacology & therapeutics, 26 (5):757-66. 2007.
46. Malamut, G., El Machhour, R., Montcuquet, N., Martin-Lanneree, S., Dusanter-Fourt, I., Verkarre, V., Mention, J.J., Rahmi, G., Kiyono, H., Butz, E.A., Brousse, N., Cellier, C., Cerf-Bensussan, N., Meresse, B. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. The Journal of clinical investigation, 120 (6):2131-43. 2010.
47. Goldberg, R.F., Austen, W.G., Jr., Zhang, X., Munene, G., Mostafa, G., Biswas, S., McCormack, M., Eberlin, K.R., Nguyen, J.T., Tatlidede, H.S., Warren, H.S., Narisawa, S., Millan, J.L., Hodin, R.A. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proceedings of the National Academy of Sciences of the United States of America, 105 (9):3551-6. 2008.
48. Molnar, K., Vannay, A., Sziksz, E., Banki, N.F., Gyorffy, H., Arato, A., Dezsofi, A., Veres, G. Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease. Virchows Archiv: an international journal of pathology, 460 (2):157-61. 2012.
49. Rentea, R.M., Liedel, J.L., Fredrich, K., Welak, S.R., Pritchard, K.A., Jr., Oldham, K.T., Simpson, P.M., Gourlay, D.M. Intestinal alkaline phosphatase administration in newborns decreases systemic inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model. The Journal of surgical research, 177 (2):228-34. 2012.